Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs

Molecules. 2022 Sep 6;27(18):5770. doi: 10.3390/molecules27185770.

Abstract

The ongoing development of more and more new psychoactive substances continues to be a huge problem in 2022 affecting the European and international drug market. Through slight alterations in the structure of illicit drugs, a way to circumvent the law is created, as the created derivatives serve as legal alternatives with similar effects. A common way of structure modification is the induction of a halogen residue. Recently, halogenated derivatives of the well-known designer drug 4-methylaminorex appeared on the market and are available in various online shops. In this study, three novel halogenated 4-methylaminorex derivatives, namely 4'-fluoro-4-methylaminorex, 4'-chloro-4-methylaminorex, and 4'-bromo-4-methylaminorex, were purchased online and characterized using nuclear magnetic resonance (NMR) spectroscopy, liquid chromatography-high-resolution mass spectrometry (LC-HRMS), and chiral high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These derivatives possess two stereogenic centers, and analyses revealed that all of them were present as a racemic mixture of the trans diastereomeric form.

Keywords: 4′-bromo-4-methylaminorex; 4′-chloro-4-methylaminorex; 4′-fluoro-4-methylaminorex; HPLC-UV; LC-HRMS; NMR; chiral separation; halogenated 4-methylaminorex derivatives.

MeSH terms

  • Designer Drugs* / chemistry
  • Halogens
  • Illicit Drugs* / chemistry
  • Oxazoles / pharmacology

Substances

  • Designer Drugs
  • Halogens
  • Illicit Drugs
  • Oxazoles
  • 4-methylaminorex

Grants and funding

This research received no external funding.